Vanguard Group’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-80,612
Closed -$253K 4380
2020
Q4
$253K Buy
80,612
+11,583
+17% +$38.1K ﹤0.01% 4064
2020
Q3
$213K Buy
69,029
+34,665
+101% +$157K ﹤0.01% 3951
2020
Q2
$160K Sell
34,364
-84,614
-71% -$439K ﹤0.01% 3946
2020
Q1
$616K Sell
118,978
-785
-0.7% -$5.68K ﹤0.01% 3625
2019
Q4
$599K Hold
119,763
﹤0.01% 3761
2019
Q3
$946K Buy
119,763
+3,294
+3% +$25.7K ﹤0.01% 3667
2019
Q2
$844K Buy
116,469
+70
+0.1% +$512 ﹤0.01% 3722
2019
Q1
$931K Buy
116,399
+26,743
+30% +$251K ﹤0.01% 3640
2018
Q4
$717K Buy
89,656
+3,605
+4% +$43.2K ﹤0.01% 3655
2018
Q3
$1.32M Sell
86,051
-546
-0.6% -$6.58K ﹤0.01% 3650
2018
Q2
$771K Buy
86,597
+11,269
+15% +$99.9K ﹤0.01% 3752
2018
Q1
$665K Buy
75,328
+7,239
+11% +$74.4K ﹤0.01% 3732
2017
Q4
$695K Buy
68,089
+54,636
+406% +$660K ﹤0.01% 3684
2017
Q3
$208K Buy
13,453
+6,871
+104% +$81.1K ﹤0.01% 3912
2017
Q2
$59K Buy
6,582
+1,924
+41% +$37.7K ﹤0.01% 4019
2017
Q1
$122K Buy
4,658
+3,355
+257% +$120K ﹤0.01% 3972
2016
Q4
$58K Sell
1,303
-1,197
-48% -$38.2K ﹤0.01% 4017
2016
Q3
$39K Sell
2,500
-100
-4% -$2.76K ﹤0.01% 4049
2016
Q2
$86K Hold
2,600
﹤0.01% 4039
2016
Q1
$65K Sell
2,600
-633
-20% -$16.9K ﹤0.01% 4060
2015
Q4
$161K Buy
3,233
+106
+3% +$11.8K ﹤0.01% 4037
2015
Q3
$559K Buy
3,127
+35
+1% +$6.89K ﹤0.01% 3818
2015
Q2
$443K Buy
3,092
+33
+1% +$4.58K ﹤0.01% 3898
2015
Q1
$413K Hold
3,059
﹤0.01% 3877
2014
Q4
$548K Sell
3,059
-84
-3% -$14.9K ﹤0.01% 3697
2014
Q3
$755K Sell
3,143
-14
-0.4% -$4.68K ﹤0.01% 3590
2014
Q2
$1.38M Hold
3,157
﹤0.01% 3394
2014
Q1
$1.45M Buy
3,157
+98
+3% +$50.9K ﹤0.01% 3342
2013
Q4
$1.47M Sell
3,059
-80
-3% -$39.1K ﹤0.01% 3310
2013
Q3
$1.51M Hold
3,139
﹤0.01% 3247
2013
Q2
$1.48M Buy
+3,139
New +$1.42M ﹤0.01% 3176

Other funds holding IDXG